REGULATORY
Welfare Recipients Should Pay Difference between Generic and Branded Drug Prices: MOF
The Ministry of Finance (MOF) on October 27 called for requiring people on welfare to pay the difference between generic prices and original drug prices if they opt for branded medicines with generic substitutes available. The MOF made the pitch…
To read the full story
Related Article
- Long-Listed Drug Use by Welfare Recipients Should Require Copay: MOF
October 28, 2016
REGULATORY
- MHLW Taps Kawabata to Lead Drug Discovery Support Office
April 15, 2026
- MHLW Reviewing EMIS Data on Petro-Product Supply to Medical Institutions
April 15, 2026
- Japan Panel to Review Ferring Gene Therapy, Fujifilm Cell Product on April 20
April 14, 2026
- LDP, Ishin to Explore Role of Private Insurance in Reform Talks
April 14, 2026
- Middle East War Hitting API Air Freight, Trade Group Warns
April 13, 2026
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…





